Bruno Julianne bought CRSP

February 18, 2025 · Form 4 insider transaction

Bruno Julianne bought 650 shares of CRISPR Therapeutics AG, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction

Acquired (buy-side)

650

Price

N/A

Total value

N/A

InsiderBruno Julianne

RoleOfficer, Director

CompanyCRISPR Therapeutics AG (CRSP)

SecurityCommon Shares

Transaction codeM — Option exercise

Transaction dateFebruary 18, 2025

Filing dateFebruary 19, 2025

Shares owned after7,395

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

View the original Form 4 on SEC EDGAR